Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brooks Gentry

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Experimental and Clinical Psychopharmacology|July 17, 2013
Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedureNichole C Sanders, Michael J Mancino, W Brooks Gentry, et al.
Drugs & Aging|June 25, 2005
Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo bilobaBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2014
Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancySarah J White, Howard P Hendrickson, William T Atchley, et al.
Mabs|February 5, 2014
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human useMisty W Stevens, Rachel L Tawney, C Michael West, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humansBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
European Journal of Pharmacology|February 15, 2003
Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in ratsKelly A Byrnes-Blake, Elizabeth M Laurenzana, F Ivy Carroll, et al.
Journal of Clinical Pharmacology|January 25, 2006
Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycinBill Gurley, Martha A Hubbard, D Keith Williams, et al.
Vaccine|October 6, 2009
Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in ratsElizabeth M Laurenzana, Howard P Hendrickson, Dylan Carpenter, et al.
Clinical Pharmacology and Therapeutics|November 13, 2004
In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmettoBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical developmentElizabeth M Laurenzana, Misty W Stevens, John C Frank, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Experimental and Clinical Psychopharmacology|July 17, 2013
Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedureNichole C Sanders, Michael J Mancino, W Brooks Gentry, et al.
Drugs & Aging|June 25, 2005
Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo bilobaBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2014
Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancySarah J White, Howard P Hendrickson, William T Atchley, et al.
Mabs|February 5, 2014
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human useMisty W Stevens, Rachel L Tawney, C Michael West, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humansBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
European Journal of Pharmacology|February 15, 2003
Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in ratsKelly A Byrnes-Blake, Elizabeth M Laurenzana, F Ivy Carroll, et al.
Journal of Clinical Pharmacology|January 25, 2006
Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycinBill Gurley, Martha A Hubbard, D Keith Williams, et al.
Vaccine|October 6, 2009
Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in ratsElizabeth M Laurenzana, Howard P Hendrickson, Dylan Carpenter, et al.
Clinical Pharmacology and Therapeutics|November 13, 2004
In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmettoBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical developmentElizabeth M Laurenzana, Misty W Stevens, John C Frank, et al.
Pageof 3